SRZN

Surrozen, Inc./DE

Healthcare · Biotechnology

$52.21 sample

+0.35 (+0.67%) 1D

Market cap

$50.1B

Price as of

2026-10-04

Latest filing

8-K · 2026-09-18

Alerts

8

Price$52.21 -5.93% 3M daily closessample

56.0751.54

2026-07-072026-07-292026-08-202026-09-102026-10-02

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Sep 29INSInsider sell: 10% owner
Sep 23INSInsider buy: General Counsel
Sep 18SECForm 144 filed
Sep 15INSInsider sell: Chief Executive Officer
Sep 10INSInsider sell: Director
Sep 03SECForm 144 filed
Aug 27INSInsider sell: Chief Executive Officer
Aug 18INSInsider sell: Director

Sign up to see the real SRZN record →

Company facts

SEC EDGAR registration

Name: Surrozen, Inc./DE
Sector: Healthcare
Industry: Biotechnology
Smart-money score: -36sample, -100 to +100
Reporting currency: USD

Who is positioning in SRZN

sample

Insiders: 9 insider transactions over 90 days, net selling, $295.3M
Congress: 2 members traded over 90 days
Institutions · 13F: 20 funds hold $326.9M
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$3.0B +14.0% y/y

Q4 2024Q3 2026

Inventory$1.7B +8.1% y/y

Q4 2024Q3 2026

Accounts receivable$1.3B +7.5% y/y

Q4 2024Q3 2026

Total debt$3.6B +7.3% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $16.7B +3.6% 3M
Sample peer B: $33.5B -9.9% 3M
Sample peer C: $44.3B +1.5% 3M
Sample peer D: $13.4B -13.3% 3M
Sample peer E: $32.1B +10.3% 3M